Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.

International journal of oncology

Volumn 25, Issue 6, 2004, Pages 1531-1536

  Nukatsuka, Mamoru ^a   Fujioka, Akio ^a   Nakagawa, Fumio ^a   Oshimo, Hideyuki ^a   Kitazato, Kenji ^a   Uchida, Jyunji ^a   Sugimoto, Yoshikazu ^a   Nagayama, Sekio ^a   Fukushima, Masakazu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; PACLITAXEL; PYRIDINE DERIVATIVE; S 1 (COMBINATION); TEGAFUR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BREAST TUMOR; DISEASE MODEL; DRUG COMBINATION; FEMALE; METASTASIS; MOUSE; MOUSE MUTANT; PATHOLOGY; XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; MICE; MICE, SCID; NEOPLASM METASTASIS; OXONIC ACID; PACLITAXEL; PYRIDINES; TEGAFUR; TRANSPLANTATION, HETEROLOGOUS;

MLCS; MLOWN;

EID: 16644397382     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.25.6.1531     Document Type: Article

References (0)